AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26409403 — intervention group
Group type: COMPARATOR
Intervention: Sham repetitive sacral root magnetic stimulation
Number of subjects: 44
Study 23993053 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 4.5‐mm screws
Number of subjects: 10
Study 23993053 — intervention group
Group type: COMPARATOR
Intervention: Three 3.5‐mm screws
Number of subjects: 10
Study 21194921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure bands (Pressure Right) (Group A)
Number of subjects: 340
Study 21194921 — intervention group
Group type: COMPARATOR
Intervention: Sham placebo bands (Group P)
Number of subjects: 340
Study 21194921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure bands (Group A)
Number of subjects: 340
Study 18312754 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg/day for 1 month
Number of subjects: 17
Study 18312754 — intervention group
Group type: COMPARATOR
Intervention: Standard clopidogrel 75 mg/day
Number of subjects: 17
Study 17003431 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational cartoon story, reward stickers, and an information sheet for the parents
Number of subjects: 310
Study 17003431 — intervention group
Group type: COMPARATOR
Intervention: Picture to color (reference group)
Number of subjects: 310
Study 17003431 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 310
Study 12675873 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors (urinary protein ≥3 g/day and systolic blood pressure ≥140 mm Hg)
Number of subjects: 0
Study 11140330 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose interferon alpha (IFN-alpha) treatment
Number of subjects: 11
Study 8812622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl anesthesia (FA)
Number of subjects: 17
Study 8243376 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM) as add-on treatment
Number of subjects: 0
Study 8243376 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM) as monotherapy
Number of subjects: 0
Study 8243376 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM) as add-on therapy
Number of subjects: 0
Study 8243376 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM)
Number of subjects: 0
Study 2869850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of catecholamines with alpha 2 agonist activity (60-120 min)
Number of subjects: 0
Study 30231101 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical interface (CI)
Number of subjects: 141
Study 30231101 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat-to-flat interface (FI)
Number of subjects: 141
Study 30231101 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switch interface (PS)
Number of subjects: 141
Study 27741949 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 50 mg every 6 hours
Number of subjects: 197
Study 27741949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 27741949 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 197
Study 25335327 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigui Mixture (QM), 200 mL per day, twice daily, and Qigui Huoxue Lotion (QHL) foot bath for 10-15 min every evening for 3 months
Number of subjects: 62
Study 25335327 — intervention group
Group type: COMPARATOR
Intervention: Mecobalamine Tablet, 500 microg each time, 3 times per day
Number of subjects: 62
Study 21851147 — intervention group
Group type: EXPERIMENTAL
Intervention: Process simulations (mental simulations of seeing the dentist)
Number of subjects: 75
Study 21851147 — intervention group
Group type: COMPARATOR
Intervention: Control condition (mental simulations of the outcome of seeing the dentist)
Number of subjects: 75
Study 21851147 — intervention group
Group type: EXPERIMENTAL
Intervention: Process simulations
Number of subjects: 75
Study 21851147 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 75
Study 19854523 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention
Number of subjects: 19
Study 19854523 — intervention group
Group type: COMPARATOR
Intervention: Control group (comprehensive disease management alone)
Number of subjects: 19
Study 17874333 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg per day)
Number of subjects: 12
Study 17874333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16252735 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrine injection (150 mg once a day for two weeks)
Number of subjects: 122
Study 16252735 — intervention group
Group type: COMPARATOR
Intervention: Control group (other same hepatinica)
Number of subjects: 122
Study 12356155 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined electrocautery pencil and suction with intravenous infusion catheter
Number of subjects: 80
Study 12356155 — intervention group
Group type: COMPARATOR
Intervention: Conventional method with electrocautery pencil and separate metal suction tube
Number of subjects: 80
Study 10358229 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic solution
Number of subjects: 47
Study 10358229 — intervention group
Group type: COMPARATOR
Intervention: Regular handwashing (liquid soap and water)
Number of subjects: 47
Study 10358229 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both methods
Number of subjects: 47
Study 8954418 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase/streptodornase (Varidase) in a hydrogel (KY Jelly)
Number of subjects: 17
Study 8954418 — intervention group
Group type: COMPARATOR
Intervention: Hydrogel alone
Number of subjects: 17
Study 2014088 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% podofilox
Number of subjects: 72
Study 2014088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 7049308 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intraparietal (intra-incisional) injection of cefoxitin
Number of subjects: 181
Study 7049308 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cefoxitin)
Number of subjects: 181
Study 31734556 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 132
Study 31734556 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 132
Study 31734556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 30203774 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib combined with transcatheter arterial chemoembolization (TACE)
Number of subjects: 0
Study 30203774 — intervention group
Group type: COMPARATOR
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 0
Study 30203774 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib alone
Number of subjects: 0
Study 26783095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab monthly
Number of subjects: 1185
Study 24194506 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin alone
Number of subjects: 0
Study 24194506 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide plus metformin
Number of subjects: 0
Study 24194506 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (3 months) followed by metformin (9 months)
Number of subjects: 0
Study 24194506 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric banding
Number of subjects: 0
Study 24194506 — intervention group
Group type: COMPARATOR
Intervention: Metformin (24 months)
Number of subjects: 0
Study 24194506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23055415 — intervention group
Group type: EXPERIMENTAL
Intervention: IV delta‐9‐tetrahydrocannabinol (THC) 2.5 mg
Number of subjects: 22
Study 23055415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 19376789 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided TAP block (Group A, n=21)
Number of subjects: 42
Study 19376789 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B, n=21)
Number of subjects: 42
Study 17902186 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg Ginkgo biloba extract (GBE)
Number of subjects: 78
Study 17902186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 15139796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 6.9 mg [14C]ciclesonide
Number of subjects: 6
Study 15139796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.64 mg [14C]ciclesonide
Number of subjects: 6
Study 11167279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular blood flow tonometer (OBF)
Number of subjects: 99
Study 11167279 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonopen XL
Number of subjects: 99
Study 11167279 — intervention group
Group type: COMPARATOR
Intervention: Goldmann applanation tonometer
Number of subjects: 99
Study 9747866 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide, doxorubicin, and 5-flurouracil) dose-intensive treatment
Number of subjects: 992
Study 7873475 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone
Number of subjects: 0
Study 7873475 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 3279143 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray
Number of subjects: 73
Study 3279143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 31006955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-Propitocain Cream (EMLA)
Number of subjects: 30
Study 31006955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29622355 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent graft placement after balloon angioplasty
Number of subjects: 98
Study 29622355 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty alone
Number of subjects: 98
Study 27151903 — intervention group
Group type: EXPERIMENTAL
Intervention: 17α‐hydroxyprogesterone caproate treatment
Number of subjects: 657
Study 27151903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 657
Study 27151903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length
Number of subjects: 657
Study 27151903 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic curve
Number of subjects: 657
Study 25614597 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding (BH) in preeclamptic women
Number of subjects: 50
Study 25614597 — intervention group
Group type: COMPARATOR
Intervention: Breath holding (BH) in normotensive women
Number of subjects: 50
Study 25614597 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding (BH) in both groups
Number of subjects: 50
Study 24024320 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese kidney-nourishing medicine (Tiankui capsule)
Number of subjects: 67
Study 24024320 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture alone
Number of subjects: 67
Study 20699507 — intervention group
Group type: EXPERIMENTAL
Intervention: ALT testing in seronegative blood donors
Number of subjects: 200
Study 20699507 — intervention group
Group type: EXPERIMENTAL
Intervention: ALT testing
Number of subjects: 200
Study 18629471 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 14
Study 18629471 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV)
Number of subjects: 14
Study 16616164 — intervention group
Group type: EXPERIMENTAL
Intervention: manualized 24-session treatment incorporating motivational interviewing and emotion coping and communication skills
Number of subjects: 16
Study 12865901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin (cholecystokinin-B receptor agonist)
Number of subjects: 17
Study 12865901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 10859510 — intervention group
Group type: EXPERIMENTAL
Intervention: interferon-alpha/isotretinoin
Number of subjects: 15
Study 10859510 — intervention group
Group type: COMPARATOR
Intervention: interferon-alpha/placebo
Number of subjects: 15
Study 9081682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet with fish oil capsules (6 or 12 capsules daily)
Number of subjects: 120
Study 9081682 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet with fish
Number of subjects: 120
Study 9081682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet with fish
Number of subjects: 120
Study 9081682 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 120
Study 8256107 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg salt weekly (n = 157)
Number of subjects: 359
Study 8256107 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg daily for 3 days followed by 250 mg weekly (n = 46)
Number of subjects: 359
Study 8256107 — intervention group
Group type: COMPARATOR
Intervention: 300 mg weekly chloroquine (n = 156)
Number of subjects: 359
Study 3698594 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive calendar
Number of subjects: 99
Study 3698594 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo album
Number of subjects: 99
Study 3698594 — intervention group
Group type: COMPARATOR
Intervention: General practice records
Number of subjects: 99
Study 31214256 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (5 sessions of bilateral 10 Hz rTMS over primary motor areas)
Number of subjects: 15
Study 31214256 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (5 sessions of similar sham stimulation)
Number of subjects: 15
Study 28076983 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 169
Study 28076983 — intervention group
Group type: COMPARATOR
Intervention: Individual Psychotherapy (IP)
Number of subjects: 169
Study 27614658 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of prednisone daily for 7 days
Number of subjects: 726
Study 27614658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 24632279 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) treatment in patients with DM and type B2/C lesions
Number of subjects: 18441
Study 24632279 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment in patients without DM and type B2/C lesions
Number of subjects: 18441
Study 24632279 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) treatment in patients with DM and type A/B1 lesions
Number of subjects: 18441
Study 24632279 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment in patients without DM and type A/B1 lesions
Number of subjects: 18441
Study 24632279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac death or myocardial infarction in patients with DM
Number of subjects: 18441
Study 24632279 — intervention group
Group type: COMPARATOR
Intervention: Cardiac death or myocardial infarction in patients without DM
Number of subjects: 18441
Study 22282543 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg, 150 mg once daily for 3 days then 150 mg twice daily)
Number of subjects: 540
Study 22282543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 22282543 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 540
Study 20606533 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16/18 AS04‐adjuvanted vaccine
Number of subjects: 1040
Study 20606533 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis A vaccine
Number of subjects: 1040
Study 17655704 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin administered during two cycles of treatment
Number of subjects: 6
Study 17655704 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 6
Study 15228063 — intervention group
Group type: EXPERIMENTAL
Intervention: Jellyfish sting inhibitor (Nidaria Technology Ltd, Jordan Valley, Israel)
Number of subjects: 24
Study 15228063 — intervention group
Group type: COMPARATOR
Intervention: Conventional sunscreen
Number of subjects: 24
Study 15228063 — intervention group
Group type: EXPERIMENTAL
Intervention: Jellyfish sting inhibitor
Number of subjects: 24
Study 12142558 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-4, subcutaneous injection at a dose of 5 microg/kg/d, daily for 28 days followed by a 7-day rest period
Number of subjects: 49
Study 9657628 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 216
Study 9657628 — intervention group
Group type: COMPARATOR
Intervention: Felodipine
Number of subjects: 216
Study 7644244 — intervention group
Group type: EXPERIMENTAL
Intervention: H-wave therapy (HWT) at various frequencies (2-60 Hz)
Number of subjects: 112
Study 7644244 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dummy power output)
Number of subjects: 112
Study 7644244 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study 2507323 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg q.p.m. or 40 mg q.p.m.)
Number of subjects: 16
Study 2507323 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate (200 mg bid)
Number of subjects: 16
Study 2507323 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 16
Study 2507323 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 16
Study 752864 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly applications of BCG
Number of subjects: 55
Study 752864 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 55
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: ACPA positive patients
Number of subjects: 53849
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: RF positive patients
Number of subjects: 53849
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ACPA titers
Number of subjects: 53849
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher RF titers
Number of subjects: 53849
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: cDMARD-exposed patients
Number of subjects: 53849
Study 31529682 — intervention group
Group type: EXPERIMENTAL
Intervention: bDMARD-exposed patients
Number of subjects: 53849
Study 30801276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic rotation
Number of subjects: 8
Study 30801276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic tilt
Number of subjects: 8
Study 30801276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic tilt (10° increase)
Number of subjects: 8
Study 30801276 — intervention group
Group type: COMPARATOR
Intervention: Pelvic rotation (± 20° of 65°)
Number of subjects: 8
Study 28499555 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing computer workstation
Number of subjects: 20
Study 28499555 — intervention group
Group type: COMPARATOR
Intervention: Sitting computer workstation
Number of subjects: 20
Study 26654907 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent paracetamol
Number of subjects: 49
Study 26654907 — intervention group
Group type: COMPARATOR
Intervention: Non-effervescent paracetamol
Number of subjects: 49
Study 22842012 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-choice question (MCQ) examination
Number of subjects: 435
Study 22842012 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 435
Study 22842012 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior physicians
Number of subjects: 435
Study 22842012 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with up-to-date PALS certification
Number of subjects: 435
Study 22842012 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory Factor Analysis (EFA)
Number of subjects: 435
Study 21120542 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme(®) Laryngeal Mask
Number of subjects: 19
Study 21120542 — intervention group
Group type: COMPARATOR
Intervention: Soft Seal(®) Laryngeal Mask
Number of subjects: 19
Study 19487394 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care (removal from institutional care)
Number of subjects: 136
Study 19487394 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (continued institutional care)
Number of subjects: 136
Study 19487394 — intervention group
Group type: COMPARATOR
Intervention: Institutional rearing (any history of institutional care)
Number of subjects: 136
Study 17283316 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective angioplasty with a balloon‐expandable stent (severe stenosis group)
Number of subjects: 213
Study 17283316 — intervention group
Group type: COMPARATOR
Intervention: Elective angioplasty with a balloon‐expandable stent (moderate stenosis group)
Number of subjects: 213
Study 17283316 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe stenosis group
Number of subjects: 213
Study 17283316 — intervention group
Group type: COMPARATOR
Intervention: Moderate stenosis group
Number of subjects: 213
Study 16115341 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplementation (120 mg vitamin C, 30 mg vitamin E, 6 mg beta-carotene, 100 microg Se, 20 mg Zn)
Number of subjects: 12741
Study 16115341 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplementation
Number of subjects: 12741
Study 16115341 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 12741
Study 16115341 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline antioxidant status
Number of subjects: 12741
Study 11805628 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural steroid injections
Number of subjects: 48
Study 11805628 — intervention group
Group type: COMPARATOR
Intervention: Saline trigger-point injections
Number of subjects: 48
Study 10331891 — intervention group
Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 14
Study 10331891 — intervention group
Group type: EXPERIMENTAL
Intervention: Swede-O
Number of subjects: 14
Study 10331891 — intervention group
Group type: EXPERIMENTAL
Intervention: AirCast
Number of subjects: 14
Study 10331891 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Ankle
Number of subjects: 14
Study 10331891 — intervention group
Group type: COMPARATOR
Intervention: No stabilizer
Number of subjects: 14
Study 8815273 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril (10-20 mg once daily)
Number of subjects: 30